Trytosaveabit :
Ok brother! This is what I got so far! I like this for several reasons! One is the Rx to OTC they are making pretty good progress with that it seems! I also IMO feel they may be a candidate for a partnership/buyout of some of their research/pipeline/intellectual property? I only say this because of the MAIN REASON I don’t like and makes this a dangerous play! They are broke, beyond broke! They say they are not sure if they have enough capital to make it the whole year! They are looking at ways to get capital! One of the things that are looking positive is the attempt to get the FDA to approve OTC for STENDRA! Great! but the bad side of that is to save cash and concentrate on other parts of their business that may have to cut funding on that? ( honestly with the headway they’re making with the FDA and that, I don’t see them cutting funding there ) that’s JMO! I can go deeper, and I will! Like I said this is a higher risk swing IMO? But I also believe that there is some really good upside? But it also appears that more updates/information about FDA progress is a few months or more away? Hope this helps a bit for now?
JESSE JAMES8832OPTrytosaveabit:
very good dd thats why i asked you to look im not very good at making sense of balance sheets n all that just yet. thanks for DD
TrytosaveabitJESSE JAMES8832OP:
Yes it’s true! But it’s just a update! They still probably won’t make much more PR from it until at least Q2? At least from what I’ve found so far! Give me a minute I’ll get something on it for you
Trytosaveabit : Ok brother! This is what I got so far! I like this for several reasons! One is the Rx to OTC they are making pretty good progress with that it seems! I also IMO feel they may be a candidate for a partnership/buyout of some of their research/pipeline/intellectual property? I only say this because of the MAIN REASON I don’t like and makes this a dangerous play! They are broke, beyond broke! They say they are not sure if they have enough capital to make it the whole year! They are looking at ways to get capital! One of the things that are looking positive is the attempt to get the FDA to approve OTC for STENDRA! Great! but the bad side of that is to save cash and concentrate on other parts of their business that may have to cut funding on that? ( honestly with the headway they’re making with the FDA and that, I don’t see them cutting funding there ) that’s JMO! I can go deeper, and I will! Like I said this is a higher risk swing IMO? But I also believe that there is some really good upside? But it also appears that more updates/information about FDA progress is a few months or more away? Hope this helps a bit for now?
JESSE JAMES8832OP Trytosaveabit: very good dd thats why i asked you to look im not very good at making sense of balance sheets n all that just yet. thanks for DD
JESSE JAMES8832OP JESSE JAMES8832OP: someone in the group im in posted this news.. idk if it true or not yet ill try to find
Trytosaveabit JESSE JAMES8832OP: Yes it’s true! But it’s just a update! They still probably won’t make much more PR from it until at least Q2? At least from what I’ve found so far! Give me a minute I’ll get something on it for you
JESSE JAMES8832OP JESSE JAMES8832OP: yea im not finding that news on there website..